Orgenesis moved to OTC Pink Limited after failing to cure 10-K delinquency

Orgenesis Inc.

OTC Markets notified Orgenesis on June 2, 2025, that its common stock would be moved from OTCQX to Pink Limited effective June 3.
The move was triggered by the company's delinquent filing of its annual 10-K for the period ended December 31, 2024.
Orgenesis failed to remedy the deficiency within the 45-day cure period, leading to the downgrade.
The stock now trades on the OTC Pink tier, which has less stringent listing requirements.

item 3.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.